Back to Directory
research logo

Neumora | Company Profile

10/28/2025

Contact Information

👤
Neumora
🏢
Neumora
📍
65 Grove Street, Suite 102, Watertown, MA 02472, US

Industry & Market

Primary Industry
research
Location
Watertown, Massachusetts, United States
Public Trading
NASDAQ: NMRA

Company Metrics

👥Total Employees
52
⚙️Engineering
3
💼Sales Team
N/A
📈Marketing
N/A
📅Founded
2020
💰Revenue
8M

Funding Information

Market Cap
$315.8M
Annual Revenue
$8,000,000
Publicly traded company

Headcount Distribution

Total Employees
52
Departments
19

By Department

Department Breakdown

Operations
Consulting
Data Science
Business Development
Accounting
Engineering
Others

Technology Stack

Analytics & Tracking

Google AnalyticsGoogle Tag Manager

Email & Communication

Outlook
Total: 17 technologies

Keywords & Focus Areas

biotechnology: biological products (no diagnostic substances)health carebiotechnology researchtarget engagementneurodegenerative diseasestherapeutic innovationprecision diagnosticsbiotech innovationbiopharmaceuticalclinical trialstherapeutic targets cnscomputational biologytargeted treatmentsclinical pipelineneuroplasticity drugsnovel mechanismshealthcarepersonalized medicineneuroscience drug developmenttarget validation+10 more
30 total keywords

Neumora

Overview

Neumora Therapeutics is a clinical-stage biotechnology company dedicated to developing precision medicines for brain diseases. By integrating data science with neuroscience, the organization aims to create targeted therapies that address the unique biological and genetic characteristics of neuropsychiatric and neurodegenerative disorders. Focused on transforming drug development in this field, its mission parallels the transformative advancements made in oncology.

With a robust pipeline of eight potential best-in-class precision medicines, Neumora targets conditions such as Major Depressive Disorder, Alzheimer’s Disease, Schizophrenia, and Parkinson’s Disease, utilizing specific biomarkers and patient stratification strategies to enhance clinical efficacy. Collaborations with clinical investigator sites in the United States, Canada, and Sweden expand its clinical trial network. Supported by over $500 million in capital and a strategic partnership with Amgen, the organization is positioned to lead innovation in neuroscience drug development, addressing significant unmet needs among patients with complex brain diseases.

Basic Information

Industry research
Founded 2020
Revenue 8M
Headquarters 65 Grove Street, Watertown, MA 02472, United States

Contact Details

Key Focus Areas & Initiatives

  • Biotechnology research
  • Neuroscience drug development
  • Precision medicine for brain diseases
  • Biomarker-guided therapy & patient stratification
  • Development of novel CNS-targeted therapies
  • Drug discovery & pipeline management
  • Clinical trial design and management
  • Collaboration with global clinical investigators
  • Therapeutic innovation in neuropsychiatric and neurodegenerative disorders
  • Data science integration in medicine
  • Translational science & clinical research
  • Addressing unmet needs in neuroscience and mental health

Technologies Used

  • AI
  • Atlassian Cloud
  • Circle
  • Google Analytics
  • Google Cloud Hosting
  • Google Tag Manager
  • Gravity Forms
  • Microsoft Office 365
  • Mobile Friendly
  • Nginx
  • Outlook
  • Remote
  • Render
  • Route 53
  • WP Engine
  • WordPress.org
  • reCAPTCHA

Affiliated Organizations & Regional Branches

    Need more information?

    Find decision makers, more insights and contact information about this company on Bitscale

    Try Bitscale Now

    Schedule your demo now!

    See how BitScale can supercharge your outbound sales in a 30-minute demo

    SayData

    © 2025 Bitscale. Featherflow Technology Pvt Ltd

    LinkedInTwitterInstagramYouTube